Home › Companies › INTELLIA THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and INTELLIA THERAPEUTICS INC.’s Form 8-K, filed June 13, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 12, 2024: 2 items on INTELLIA THERAPEUTICS INC.’s Form 8-K, filed June 13, 2024: 2 passed (calculated).
Significant dissent: 1 director (22.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore INTELLIA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are INTELLIA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Fred Cohen, M.D., D.Phil. | 65,390,554 | -- | -- | 6,655,846 | 11,843,099 | 91% | Passed (calculated) | — |
| Elect Director: Frank Verwiel, M.D. | 55,820,159 | -- | -- | 16,226,241 | 11,843,099 | 77% | Passed (calculated) | — |
Source: INTELLIA THERAPEUTICS INC., Form 8-K, filed with the SEC on June 13, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
342 asset managers disclosed a vote on at least one INTELLIA THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of INTELLIA THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2027: Frank Verwiel, M.D.
INTELLIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Frank Verwiel, M.D.”): 55,820,159 for, 16,226,241 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 86 asset managers below reported 34,602,219 for, 70 against, 2,789,197 withheld, 140,555 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,223,933 | 0 | 0 | 0 | For |
| ARK ETF Trust | 9,826,734 | 0 | 0 | 0 | For |
| Fidelity | 2,559,299 | 0 | 0 | 19,978 | For |
| State Street | 2,434,828 | 0 | 0 | 35,401 | For |
| Federated Hermes | 1,929,700 | 0 | 0 | 0 | For |
| BlackRock | 1,404,146 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,179,178 | 0 | 0 | 0 | For |
| Charles Schwab | 730,022 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 546,754 | Withhold |
| Dimensional | 0 | 0 | 0 | 510,760 | Withhold |
| Equitable | 175,303 | 0 | 0 | 205,641 | Mixed |
| TIAA | 369,033 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 304,792 | Withhold |
| Morgan Stanley | 269,635 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 252,270 | 0 | 0 | 0 | For |
| Global X | 174,665 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 167,097 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 162,429 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 160,000 | Withhold |
| Hartford | 159,764 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 154,269 | Withhold |
| Principal | 579 | 0 | 0 | 119,620 | Withhold |
| JPMorgan | 109,027 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 94,561 | 0 | Abstain |
| Lincoln Financial | 79,536 | 0 | 0 | 8,782 | Mixed |
Showing the 25 largest of 86 asset managers. All 86 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. Election of the following individuals nominated to serve as Class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2027: Fred Cohen, M.D., D.Phil.
INTELLIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Fred Cohen, M.D., D.Phil.”): 65,390,554 for, 6,655,846 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 86 asset managers below reported 33,600,653 for, 3,789,853 withheld, 141,535 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,223,933 | 0 | 0 | 0 | For |
| ARK ETF Trust | 9,826,734 | 0 | 0 | 0 | For |
| Fidelity | 2,559,299 | 0 | 0 | 19,978 | For |
| State Street | 2,463,328 | 0 | 0 | 6,901 | For |
| Federated Hermes | 0 | 0 | 0 | 1,929,700 | Withhold |
| BlackRock | 1,404,146 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,179,178 | 0 | 0 | 0 | For |
| Charles Schwab | 730,022 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 546,754 | Withhold |
| Dimensional | 0 | 0 | 0 | 510,760 | Withhold |
| Equitable | 175,303 | 0 | 0 | 205,641 | Mixed |
| TIAA | 369,033 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 304,792 | Withhold |
| Morgan Stanley | 269,635 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 252,270 | 0 | 0 | 0 | For |
| Global X | 174,665 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 167,097 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 162,429 | 0 | 0 | 0 | For |
| Goldman Sachs | 160,000 | 0 | 0 | 0 | For |
| Hartford | 159,764 | 0 | 0 | 0 | For |
| Aberdeen | 154,269 | 0 | 0 | 0 | For |
| Principal | 10,564 | 0 | 0 | 109,635 | Mixed |
| JPMorgan | 0 | 0 | 109,027 | 0 | Abstain |
| Jackson National | 78,755 | 0 | 15,806 | 0 | Mixed |
| Lincoln Financial | 77,243 | 0 | 6,236 | 4,839 | Mixed |
Showing the 25 largest of 86 asset managers. All 86 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% of fund votes cast · no official result
Description as filed by funds: Approval of a second amendment to our Second Amended and Restated Certificate of Incorporation, as amended, to limit the liability of certain officers of the Company as permitted by recent amendments to the Delaware General Corporation Law.
The 86 asset managers below reported 37,098,648 for, 414,298 against, 19,095 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,223,933 | 0 | 0 | 0 | For |
| ARK ETF Trust | 9,826,734 | 0 | 0 | 0 | For |
| Fidelity | 2,579,277 | 0 | 0 | 0 | For |
| State Street | 2,466,056 | 4,173 | 0 | 0 | For |
| Federated Hermes | 1,929,700 | 0 | 0 | 0 | For |
| BlackRock | 1,404,146 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,179,178 | 0 | 0 | 0 | For |
| Charles Schwab | 730,022 | 0 | 0 | 0 | For |
| AllianceBernstein | 546,754 | 0 | 0 | 0 | For |
| Dimensional | 510,760 | 0 | 0 | 0 | For |
| Equitable | 380,944 | 0 | 0 | 0 | For |
| TIAA | 369,033 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 304,792 | 0 | 0 | 0 | For |
| Morgan Stanley | 269,635 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 252,270 | 0 | 0 | 0 | For |
| Global X | 0 | 174,665 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 167,097 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 162,429 | 0 | 0 | 0 | For |
| Goldman Sachs | 160,000 | 0 | 0 | 0 | For |
| Hartford | 159,764 | 0 | 0 | 0 | For |
| Aberdeen | 154,269 | 0 | 0 | 0 | For |
| Principal | 120,199 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 109,027 | 0 | 0 | Against |
| Jackson National | 94,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 82,082 | 6,236 | 0 | 0 | Mixed |
Showing the 25 largest of 86 asset managers. All 86 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
99% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,223,933 | 0 | 0 | 0 | For |
| ARK ETF Trust | 9,826,734 | 0 | 0 | 0 | For |
| Fidelity | 2,579,277 | 0 | 0 | 0 | For |
| State Street | 2,470,229 | 0 | 0 | 0 | For |
| Federated Hermes | 1,929,700 | 0 | 0 | 0 | For |
| BlackRock | 1,404,146 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,179,178 | 0 | 0 | 0 | For |
| Charles Schwab | 730,022 | 0 | 0 | 0 | For |
| AllianceBernstein | 546,754 | 0 | 0 | 0 | For |
| Dimensional | 510,760 | 0 | 0 | 0 | For |
| Equitable | 380,944 | 0 | 0 | 0 | For |
| TIAA | 369,033 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 304,792 | 0 | 0 | 0 | For |
| Morgan Stanley | 269,635 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 252,270 | 0 | 0 | 0 | For |
| Global X | 174,665 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 167,097 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 162,429 | 0 | 0 | 0 | For |
| Goldman Sachs | 160,000 | 0 | 0 | 0 | For |
| Hartford | 159,764 | 0 | 0 | 0 | For |
| Aberdeen | 154,269 | 0 | 0 | 0 | For |
| Principal | 120,199 | 0 | 0 | 0 | For |
| JPMorgan | 109,027 | 0 | 0 | 0 | For |
| Jackson National | 94,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 88,318 | 0 | 0 | 0 | For |
Fund voting reports, all 85 managers: 37,500,134 for, 12,742 against, 19,095 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 4,236,986 | 0 | 0 | 0 | For |
| State Street | 4,123,298 | 0 | 0 | 0 | For |
| Wellington | 3,940,032 | 0 | 0 | 0 | For |
| Nikko Asset Management Americas, Inc. | 3,026,600 | 0 | 0 | 0 | For |
| BlackRock | 2,043,438 | 0 | 0 | 0 | For |
| Federated Hermes | 1,929,700 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,549,755 | 0 | 0 | 0 | For |
| Fidelity | 1,517,440 | 9,629 | 0 | 0 | For |
| Contrarius Investment Management Ltd | 1,450,033 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,393,043 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,137,075 | 0 | 0 | 0 | For |
| CHEVY CHASE TRUST Co | 1,033,843 | 0 | 0 | 0 | For |
| Charles Schwab | 744,935 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 693,563 | 0 | 0 | 0 | For |
| Northern Trust | 506,773 | 59 | 0 | 0 | For |
| Two Sigma | 501,567 | 0 | 0 | 0 | For |
| Morgan Stanley | 439,090 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 433,941 | 0 | 0 | 0 | For |
| Nuveen | 383,847 | 0 | 0 | 0 | For |
| Nikko Asset Management Co., Ltd. | 347,239 | 0 | 0 | 0 | For |
| Vestmark Advisory Solutions, Inc. | 346,026 | 0 | 0 | 0 | For |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | 306,366 | 0 | 0 | Against |
| CAPITAL ADVISORS INC/OK | 270,649 | 0 | 0 | 0 | For |
| Goldman Sachs | 216,946 | 0 | 0 | 0 | For |
| Opaleye Management Inc. | 205,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 270 managers: 35,936,850 for, 1,014,755 against, 10,203 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.8% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Ultimus Managers Trust | 10,915 | 0 | 0 | 0 | For |
Fund voting reports, all 1 managers: 10,915 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Orchard Capital Management, LLC | 160,605 | 0 | 0 | 0 | For |
| NICHOLS & PRATT ADVISERS LLP /MA | 0 | 400 | 0 | 0 | Against |
| TOWNSEND ASSET MANAGEMENT CORP /NC/ /ADV | 312 | 0 | 0 | 0 | For |
| PEDDOCK CAPITAL ADVISORS, LLC | 202 | 0 | 0 | 0 | For |
| Investment Partners Asset Management, Inc. | 0 | 0 | 45 | 0 | Abstain |
| GRIMES & COMPANY, INC. | 28 | 0 | 0 | 0 | For |
Institutional-manager reports, all 6 managers: 161,147 for, 400 against, 45 abstained.
99.3% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Advisors' Inner Circle Fund III | 23,052 | 0 | 0 | 0 | For |
Fund voting reports, all 1 managers: 23,052 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rokos Capital Management LLP | 1,463,630 | 0 | 0 | 0 | For |
| JPMorgan | 450,387 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 14,419 | 0 | 0 | Against |
| TD ASSET MANAGEMENT INC | 250 | 0 | 0 | 0 | For |
| SCHARF INVESTMENTS, LLC | 228 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 70 | 0 | 0 | 0 | For |
Institutional-manager reports, all 6 managers: 1,914,565 for, 14,419 against.
Combines 4 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as Intellia's independent registered public accounting firm for the fiscal year ending December 31, 2024
The 86 asset managers below reported 37,508,773 for, 4,173 against, 19,095 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,223,933 | 0 | 0 | 0 | For |
| ARK ETF Trust | 9,826,734 | 0 | 0 | 0 | For |
| Fidelity | 2,579,277 | 0 | 0 | 0 | For |
| State Street | 2,466,056 | 4,173 | 0 | 0 | For |
| Federated Hermes | 1,929,700 | 0 | 0 | 0 | For |
| BlackRock | 1,404,146 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,179,178 | 0 | 0 | 0 | For |
| Charles Schwab | 730,022 | 0 | 0 | 0 | For |
| AllianceBernstein | 546,754 | 0 | 0 | 0 | For |
| Dimensional | 510,760 | 0 | 0 | 0 | For |
| Equitable | 380,944 | 0 | 0 | 0 | For |
| TIAA | 369,033 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 304,792 | 0 | 0 | 0 | For |
| Morgan Stanley | 269,635 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 252,270 | 0 | 0 | 0 | For |
| Global X | 174,665 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 167,097 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 162,429 | 0 | 0 | 0 | For |
| Goldman Sachs | 160,000 | 0 | 0 | 0 | For |
| Hartford | 159,764 | 0 | 0 | 0 | For |
| Aberdeen | 154,269 | 0 | 0 | 0 | For |
| Principal | 120,199 | 0 | 0 | 0 | For |
| JPMorgan | 109,027 | 0 | 0 | 0 | For |
| Jackson National | 94,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 88,318 | 0 | 0 | 0 | For |
Showing the 25 largest of 86 asset managers. All 86 are in the interactive database (link above).
100% of fund votes cast · no official result
The 2 asset managers below reported 33,967 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Advisors' Inner Circle Fund III | 23,052 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 10,915 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 96,333,373 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.69% |
| 2 | ARK ETF Trust | 10.20% |
| 3 | Fidelity | 2.68% |
| 4 | State Street | 2.56% |
| 5 | Federated Hermes | 2.00% |
| 6 | BlackRock | 1.46% |
| 7 | T. Rowe Price | 1.22% |
| 8 | Charles Schwab | 0.76% |
| 9 | AllianceBernstein | 0.57% |
| 10 | Dimensional | 0.53% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Deep Track Capital, LP | 4.40% |
| 2 | State Street | 4.28% |
| 3 | Wellington | 4.09% |
| 4 | Nikko Asset Management Americas, Inc. | 3.14% |
| 5 | BlackRock | 2.12% |
| 6 | Federated Hermes | 2.00% |
| 7 | T. Rowe Price | 1.61% |
| 8 | Fidelity | 1.59% |
| 9 | Contrarius Investment Management Ltd | 1.51% |
| 10 | AllianceBernstein | 1.45% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 11,044,820 | 11.47% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 9,275,817 | 9.63% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 6,022,576 | 6.25% | Form 13F, quarter ended March 31, 2024 |
| State Street | 4,597,822 | 4.77% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 4,278,677 | 4.44% | Form 13F, quarter ended March 31, 2024 |
| Wellington Management | 4,162,129 | 4.32% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 2,044,257 | 2.12% | Form 13F, quarter ended March 31, 2024 |
| FMR (Fidelity) | 1,852,292 | 1.92% | Form 13F, quarter ended March 31, 2024 |
| T. Rowe Price | 1,625,051 | 1.69% | Form 13F, quarter ended March 31, 2024 |
| Dimensional Fund Advisors | 1,225,696 | 1.27% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 96,333,373 shares outstanding, as reported by INTELLIA THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At INTELLIA THERAPEUTICS INC.'s shareholder meeting held June 12, 2024, in the 2023-2024 proxy season, 342 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,873 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. INTELLIA THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approve, on a non-binding advisory basis, the compensation of the named executive officers. — the reporting funds and managers cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from INTELLIA THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
INTELLIA THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “INTELLIA THERAPEUTICS (NTLA) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/intellia-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.